Bryce Kerlin, MD

Project Title: “Direct oral anticoagulants for simultaneous disease treatment and thromboprophylaxis in nephrotic syndrome.”

The 2020 HTRS Mid-Career Research Award Program is supported by a grant from Genentech, a member of the Roche Group.